InsidersTradesSigma
Browse the full record of transactions filed by LLOYD RONALD K., Chairman & CEO. Director active across 1 companies, notably Aziyo Biologics, INC.. Cumulatively, 1 reports have been recorded. The latest transaction was filed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Ronald K. Lloyd is the President and CEO of Aziyo Biologics, Inc. He is responsible for the strategic direction of the company, which specializes in developing biological solutions for regenerative medicine. Aziyo Biologics, Inc. is committed to improving patient outcomes through innovative technologies.